Ayble Health Recognized as the First and Only Gastroenterology Company to Achieve Certification from the Validation Institute for IBS and IBD Patient Outcomes

Ayble Health Recognized as the First and Only Gastroenterology Company to Achieve Certification from the Validation Institute for IBS and IBD Patient Outcomes

‍

BOSTON, MA., – Ayble Health, a precision health platform for patients with chronic gastrointestinal (GI) conditions, is proud to announce it has achieved certification from the Validation Institute, independently validating its best-in-class outcomes improvement claims for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Ayble Health is the first and only GI company to meet the robust standards from the esteemed institute.

‍

Founded in 2020, Ayble Health is tenacious in its pursuit to transform the standard of care for GI patients. Backed by over two decades of peer-reviewed research on tens of thousands of patients and three years of its own published primary clinical research, Ayble Health continuously improves upon gold-standard approaches for the management of both Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD).

‍

Ayble Health’s data-driven, personalized nutrition program, backed by researchers at Harvard Medical School, Northwestern Feinberg School of Medicine, Massachusetts General Hospital and Brigham & Women’s, helps GI patients identify their unique trigger foods and builds a customized diet that measurably improves their symptoms:

• 81% of IBD and IBS patients using Ayble significantly improve their clinical symptoms (Jactel et al., 2022);
• 89% of users report significantly better quality of life, 95% improve their ability to make healthy digestive choices and 89% feel more empowered and in control of their digestive health (Jactel et al., 2022);
• 89% of Ayble users are adherent to program recommendations, with a 92% average satisfaction score (Jactel et al., 2022).

‍

Compared to the current gold-standard of care in gastroenterology, The Validation Institute’s  Outcomes Report also emphasizes that Ayble’s precision nutrition program:

• Is 2x more effective as in-person or virtual dietetics, measured by symptom improvement;
• Drives 30-40% better adherence to recommendations.

‍

The Validation Institute is dedicated to driving transparency in the marketplace by providing unbiased, data-driven insights on healthcare solutions. Ayble’s Outcomes Validation carries a $25,000 guarantee as part of the Validation Institute’s Credibility Guarantee Program. 

‍

“The clinical results we found with Ayble Health are exceptional. We are thrilled to recognize Ayble Health as the first and only GI company to receive our validation and are excited to see such a robust program be launched for a patient population that has been long overlooked,” said Benny DiCecca, CEO of the Validation Institute.

‍

Gastrointestinal issues impact upwards of 70 million Americans (25% of a commercially insured population) and drive over $140B in direct medical costs each year, more than mental health, trauma and heart disease. Despite the significant unmet needs in the space, patients continue to lack access to evidence-based dietary and psychological therapy. 

‍

“There’s been an incredible proliferation of digital health companies across a range of disease states, but there has been a worrying gap between the claims some companies make and the evidence they provide to substantiate them,” said Sam Jactel, founder and CEO of Ayble Health. “Clinical excellence and rigorous evaluation of our claims has always been - and will always be - at the core of what we do at Ayble. We’re proud to receive this recognition and are excited to be part of a phenomenal network of other clinically-focused, mission driven businesses.”

‍

Ayble’s unique complementary digital model ensures patients with chronic GI conditions get better care earlier in their disease progression, improve access to an ecosystem of evidence-based support to manage symptoms, and address health equity disparities in GI.  Employers and insurers partner with Ayble to manage disease-related healthcare costs and improve member quality of life, while providers collaborate with Ayble to extend care beyond the four walls of the clinic and deliver AGA-recommended dietary and behavioral therapy.

__________________________________________________________________________

‍

Ayble Health

Ayble Health is a precision health platform empowering patients with chronic GI conditions such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) to manage their care beyond the pill. Ayble combines the largest GI behavioral health database in the world with its proprietary machine learning algorithms to build personalized, predictive care for every patient - all with the human touch of a licensed care team. Ayble’s platform is built on 20 years of research, including publications in Gastroenterology, Inflammatory Bowel Diseases and Clinical & Translational Gastroenterology, and it is accredited by the American Nutrition Association. Patients can find Ayble through their physician partners, employers, insurers or directly online. Visit ayblehealth.com. 

‍

Validation Institute

Validation Institute is dedicated to providing unbiased, data-driven insights on health care solutions and services by validating performance claims made by solutions providers and educating purchasers to drive transparency in the marketplace and maximize cost-savings. Visit validationinstitute.com.

‍

#####

‍